These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15337519)

  • 1. Results from a bench marking survey on cassette dosing practices in the pharmaceutical industry.
    Ackermann BL
    J Am Soc Mass Spectrom; 2004 Sep; 15(9):1374-7. PubMed ID: 15337519
    [No Abstract]   [Full Text] [Related]  

  • 2. Results from a bench marking survey on Supporting Chemical Synthesis and Structural Elucidation in the Pharmaceutical Industry.
    Peake DA; Ackermann BL
    J Am Soc Mass Spectrom; 2005 Apr; 16(4):599-605. PubMed ID: 15871168
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights from a recent BIO survey on therapeutic protein-drug interactions.
    ; Lloyd P; Zhou H; Theil FP; Kakkar T; Nestorov I; Roberts SA
    J Clin Pharmacol; 2012 Nov; 52(11):1755-63. PubMed ID: 22167564
    [No Abstract]   [Full Text] [Related]  

  • 4. Whatever happened to cassette-dosing pharmacokinetics?
    Manitpisitkul P; White RE
    Drug Discov Today; 2004 Aug; 9(15):652-8. PubMed ID: 15279848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the risks of second medical use and dosing regimens in pharmaceutical patenting?
    Kanz C; Gerhardt F
    Pharm Pat Anal; 2014 Sep; 3(5):481-4. PubMed ID: 25374316
    [No Abstract]   [Full Text] [Related]  

  • 6. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry.
    Stone JA; Banfield C; Pfister M; Tannenbaum S; Allerheiligen S; Wetherington JD; Krishna R; Grasela DM
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):20S-30S. PubMed ID: 20881214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2015/2016 Quality Risk Management Benchmarking Survey.
    Waldron K; Ramnarine E; Hartman J
    PDA J Pharm Sci Technol; 2017; 71(5):330-345. PubMed ID: 28512175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
    Hewitt NJ; de Kanter R; LeCluyse E
    Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Information Practices Across the Pharma Industry: What Can We Learn from Benchmarking Surveys?
    Shah I; Janajreh I; Fung SM
    Ther Innov Regul Sci; 2020 Nov; 54(6):1259-1262. PubMed ID: 33180311
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug administration through enteral feeding catheters.
    Seifert CF; Johnston BA; Rojas-Fernandez C
    Am J Health Syst Pharm; 2002 Feb; 59(4):378-9. PubMed ID: 11885404
    [No Abstract]   [Full Text] [Related]  

  • 11. Benchmarking safety pharmacology regulatory packages and best practice.
    Lindgren S; Bass AS; Briscoe R; Bruse K; Friedrichs GS; Kallman MJ; Markgraf C; Patmore L; Pugsley MK
    J Pharmacol Toxicol Methods; 2008; 58(2):99-109. PubMed ID: 18692579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Take your pills, all your pills: drug makers nag patients to stay the course.
    Pollack A
    N Y Times Web; 2006 Mar; ():C1, C13. PubMed ID: 16649271
    [No Abstract]   [Full Text] [Related]  

  • 13. Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan.
    Malinowski HJ; Westelinck A; Sato J; Ong T
    J Clin Pharmacol; 2008 Aug; 48(8):900-8. PubMed ID: 18524997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical manufacturers and unit-dose packaging.
    Miller RW
    Am J Hosp Pharm; 1967 Feb; 24(2):76-8. PubMed ID: 6040684
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug spending up, inventories down, 1990 survey shows.
    Moran EJ
    Hospitals; 1990 Dec; 64(24):53-4. PubMed ID: 2249825
    [No Abstract]   [Full Text] [Related]  

  • 16. Refinement and validation of an exposure model for the pharmaceutical industry.
    McDonnell PE; Cherrie JW; Sleeuwenhoek A; Gilles A; Coggins MA
    J Environ Monit; 2011 Mar; 13(3):641-8. PubMed ID: 21264393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vendor competition, generic drugs spur drop in pharmaceutical prices.
    Seigner CA
    Mod Healthc; 1985 Oct; 15(21):56, 60-2. PubMed ID: 10317662
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry embraces virtual trial platforms.
    Dolgin E
    Nat Rev Drug Discov; 2018 Apr; 17(5):305-306. PubMed ID: 29700498
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulators and industry tackle dose-finding issues.
    Mullard A
    Nat Rev Drug Discov; 2015 Jun; 14(6):371-2. PubMed ID: 26027527
    [No Abstract]   [Full Text] [Related]  

  • 20. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.
    Swales JG; Tucker JW; Strittmatter N; Nilsson A; Cobice D; Clench MR; Mackay CL; Andren PE; Takáts Z; Webborn PJ; Goodwin RJ
    Anal Chem; 2014 Aug; 86(16):8473-80. PubMed ID: 25084360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.